Senores Pharmaceuticals vs Nifty 50: Returns Compared

Senores Pharmaceuticals share price Rs 1,320.00 on NSE. Senores Pharmaceuticals vs Nifty 50 over 1 year: +80.29% vs -10.93%. 52-week high Rs 1,599.00, low Rs 705.10.

Updated: 12 Oct 2026 • 12:59 pm

Posted by:

Senores Pharmaceuticals vs Nifty 50: Returns Compared

Quick Answer

Senores Pharmaceuticals vs Nifty 50 gives a mixed picture: Senores Pharmaceuticals has beaten the index in 3 of 4 time frames, and its 1-year return of +80.29% compares with -10.93% for the Nifty 50. Over the past month, Senores Pharmaceuticals fell 10.04% while the Nifty 50 fell 3.75%, a gap of 6.29 percentage points against it. At Rs 1,320.00, Senores Pharmaceuticals is 17.4% below its 52-week high of Rs 1,599.00 and 87.2% above its 52-week low of Rs 705.10. Returns use NSE closing prices to 9 October 2026, and past performance does not indicate future results.

Senores Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Senores Pharmaceuticals trades on the NSE under the symbol SENORES, and its 1-month return of -10.04% compares with -3.75% for the Nifty 50 over the same period.

The Senores Pharmaceuticals vs Nifty 50 comparison matters because Senores Pharmaceuticals is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Senores Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months and 1 year, using NSE closing data up to 9 October 2026. NSE price history for Senores Pharmaceuticals begins on 30 December 2024, so the table covers only the time frames with a full trading record.

Also read – Sansera Engineering vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Table of Contents

Senores Pharmaceuticals vs Nifty 50: Performance at a Glance

The table below sets out the Senores Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 9 October 2026.

Time Frame	Senores Pharmaceuticals Return	Nifty 50 Return	Difference
1 Month	-10.04%	-3.75%	-6.29 pp
3 Months	-6.90%	-6.97%	+0.07 pp
6 Months	+60.70%	-6.36%	+67.06 pp
1 Year	+80.29%	-10.93%	+91.22 pp

On the Senores Pharmaceuticals vs Nifty 50 scorecard, Senores Pharmaceuticals has beaten the index over the latest 1-year window, returning +80.29% against -10.93% for the Nifty 50, a difference of 91.22 percentage points. That is also the widest gap anywhere in the table. The direction differs over the past year: Senores Pharmaceuticals moved up while the Nifty 50 moved down.

Check the Univest Screener for live Senores Pharmaceuticals and Nifty 50 data

Latest Close and 52-Week Range: Senores Pharmaceuticals and the Nifty 50

Instrument	Latest Close	52-Week High	52-Week Low	Vs 52-Week High
Senores Pharmaceuticals	Rs 1,320.00	Rs 1,599.00	Rs 705.10	-17.4%
Nifty 50	22,520.45	26,373.20	22,179.90	-14.6%

Senores Pharmaceuticals closed at Rs 1,320.00 on 9 October 2026, which is 17.4% below its 52-week high of Rs 1,599.00 and 87.2% above its 52-week low of Rs 705.10. The Nifty 50 closed at 22,520.45, 14.6% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Senores Pharmaceuticals vs Nifty 50 Gap Exists

Senores Pharmaceuticals can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Senores Pharmaceuticals has traded between Rs 705.10 and Rs 1,599.00, a spread of 126.8% from low to high, against 18.9% for the Nifty 50.

Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move Senores Pharmaceuticals's price sharply in either direction, while the Nifty 50's return reflects the blended earnings of its constituents and is far less exposed to any single company's news.

Download the Univest iOS App or Univest Android App to track Senores Pharmaceuticals and Nifty 50 live on the go.

Senores Pharmaceuticals vs Nifty 50: Has Senores Pharmaceuticals Beaten the Benchmark?

Yes, over the past year. Senores Pharmaceuticals returned +80.29% against -10.93% for the Nifty 50, a lead of 91.22 percentage points. Across the four time frames measured, Senores Pharmaceuticals is ahead of the index over 3 months, 6 months and 1 year and behind it over 1 month.

Risks of the Senores Pharmaceuticals vs Nifty 50 Comparison

Reading too much into a Senores Pharmaceuticals vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.

Also read – Schneider Electric Infrastructure vs Nifty 50: Returns Compared

Senores Pharmaceuticals carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 705.10 to Rs 1,599.00 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Senores Pharmaceuticals vs Nifty 50 shows Senores Pharmaceuticals ahead of the index in 3 of 4 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Senores Pharmaceuticals into a wider portfolio.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Has Senores Pharmaceuticals outperformed the Nifty 50 in the last year?

Ans. Yes. Senores Pharmaceuticals returned +80.29% over the past year while the Nifty 50 returned -10.93%, based on NSE closing prices to 9 October 2026.

How does Senores Pharmaceuticals vs Nifty 50 look over the last month?

Ans. Over the past month Senores Pharmaceuticals has returned -10.04% compared with the Nifty 50's -3.75%, so in the Senores Pharmaceuticals vs Nifty 50 comparison the stock has been behind over this horizon.

What is the Senores Pharmaceuticals share price today compared to Nifty 50?

Ans. Senores Pharmaceuticals share price closed at Rs 1,320.00 on NSE on 9 October 2026, while the Nifty 50 closed at 22,520.45 in the same session.

What is the 52-week high and low of Senores Pharmaceuticals?

Ans. Senores Pharmaceuticals's 52-week high is Rs 1,599.00 and its 52-week low is Rs 705.10, based on NSE data. The latest close of Rs 1,320.00 is 17.4% below the high.

Why does Senores Pharmaceuticals show bigger price swings than the Nifty 50?

Ans. Senores Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Senores Pharmaceuticals has traded in a 126.8% low-to-high range against 18.9% for the index, a key reason the Senores Pharmaceuticals vs Nifty 50 return gap varies across time frames.

Is Senores Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?

Ans. Senores Pharmaceuticals's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Senores Pharmaceuticals vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.